John P. Kane

23.2k citations

261 papers · 16.8k indexed · 6 hit papers · h-index 70

Impact in

Endocrinology, Diabetes and Metabolism top 0.05%
- Diabetes, Cardiovascular Risks, and Lipoproteins
Cancer Research top 0.2%
- Cancer, Lipids, and Metabolism

Papers in

Endocrinology, Diabetes and Metabolism 100
- Diabetes, Cardiovascular Risks, and Lipoproteins 77
Cancer Research 71
- Cancer, Lipids, and Metabolism 59

Co-authors: Richard J. Havel Mary J. Malloy Clive R. Pullinger S T Kunitake D A Hardman R J Havel L Kotite Harold E. Paulus
Journals: Journal of Lipid Research (29 papers)Journal of Clinical Investigation (20 papers)Proceedings of the National Academy of Sciences (13 papers)Biochemistry (11 papers)Journal of clinical lipidology (9 papers)
Partner nations: United States Japan Canada

In The Last Decade

John P. Kane

258 papers receiving 16.0k citations

Hit Papers

6 papers align trajectories log scale

Regression of Coronary Atherosclerosis During Treatment of Familial Hypercholesterolemia With Combined Drug Regimens 1990 · 615 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

1990 JAMA
1981 Journal of Clinical Investigation
1980 Proceedings of the National Academy of Sciences
1973 Analytical Biochemistry
1973 Journal of Clinical Investigation
1970 Journal of Clinical Investigation

Peers

Countries citing papers authored by John P. Kane

Since Specialization

Citations

This map shows the geographic impact of John P. Kane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John P. Kane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John P. Kane more than expected).

Fields of papers citing papers by John P. Kane

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John P. Kane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John P. Kane. The network helps show where John P. Kane may publish in the future.

Co-authors

The 25 scholars most cited alongside John P. Kane, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John P. Kane Line = papers co-authored together John P. Kane links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Logistic Regression and Statistical Regularization Techniques for Risk Classification of Coronary Artery Disease Using Cytokines transported by High Density Lipoproteins PubMed ·P.S. DANNIES, Hans Lineweaver, Kate Townsend Creasy, Eveline O. Stock, Abby Mullen, Mary J. Malloy, John P. Kane	2023	3
2	Elastin Degradation and Lung Function Deterioration with Remote Secondhand Tobacco Smoke Exposure in Never-smokers Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation ·Chen De-min, 城野明子, 春男郡山, Erin L. Van Blarigan, Xingjian Liu, Shuren Ma, John P. Kane, Rita F. Redberg, Gerard M. Turino, Eveline O. Stock, Mehrdad Arjomandi	2022	3
3	Ancestry-specific profiles of genetic determinants of severe hypertriglyceridemia Journal of clinical lipidology ·R. Walker, Jacqueline S. Dron, Allison A. Dilliott, Adam D. McIntyre, Henian Cao, Jian Wang, Irina Movsesyan, Mary J. Malloy, Clive R. Pullinger, John P. Kane, Robert A. Hegele	2020	10
4	Levels of prebeta-1 high-density lipoprotein are elevated in 3 phenotypes of dyslipidemia Journal of clinical lipidology ·Eveline O. Stock, Christine T. Ferrara, Patricia OʼConnor, Josefina Naya-Vigne, Philip H. Frost, Mary J. Malloy, John P. Kane, Clive R. Pullinger	2017	13
5	Identification and metabolic profiling of patients with lysosomal acid lipase deficiency Journal of clinical lipidology ·Clive R. Pullinger, Eveline O. Stock, Irina Movsesyan, Mary J. Malloy, Philip H. Frost, S. Hanif, Anthony Quinn, Brian Y. Ishida, Ernst J. Schaefer, Bela F. Asztalos, John P. Kane	2015	30
6	Association of CASQ2 polymorphisms with sudden cardiac arrest and heart failure in patients with coronary artery disease Heart Rhythm ·Marwan M. Refaat, Bradley E. Aouizerat, Clive R. Pullinger, Mary J. Malloy, John P. Kane, Zian H. Tseng	2014	17
7	Clinical Effect And Safety Profile of Recombinant Human Lysosomal Acid Lipase in Patients With Cholesteryl Ester Storage Disease Hepatology ·Manisha Balwani, Catherine Breen, Gregory M. Enns, Patrick Deegan, Tomáš Honzík, Simon Jones, John P. Kane, Vĕra Malinová, Reena Sharma, Eveline O. Stock, Vassili Valayannopoulos, Ed Wraith, Jennifer M. Burg, Stephen Eckert, Eugene Schneider, Anthony Quinn	2013	77
8	High-density lipoprotein metabolism and the human embryo Human Reproduction Update ·Victor Y. Fujimoto, John P. Kane, Brian Y. Ishida, Michael S. Bloom, Richard W. Browne	2009	64
9	Silent growth hormone secreting pituitary adenomas. IGF-I is not sufficient to exclude growth hormone excess: 3 case reports Annals of Clinical Biochemistry International Journal of Laboratory Medicine ·蒋巧君, H Reid, John P. Kane, Helen Buckler, Peter Trainer, AH Heald	2006	1
10	The lipoprotein lipase gene in combined hyperlipidemia: evidence of a protective allele depletion Lipids in Health and Disease ·Shu‐Fen Wung, James Eiving, Clive R. Pullinger, Mary J. Malloy, John P. Kane, Bradley E. Aouizerat	2006	17
11	Expression of Reverse Cholesterol Transport Proteins SR-BI, SR-BII and ABCA1 in the Human Retinal Pigment Epithelium Investigative Ophthalmology & Visual Science ·Jay M. Stewart, Dandan Jian, Keith G. Duncan, John P. Kane, Daniel M. Schwartz	2003	1
12	Apolipoprotein L-I is the trypanosome lytic factor of human serum Nature ·Luc Vanhamme, Françoise Paturiaux-Hanocq, Philippe Poelvoorde, Derek P. Nolan, Laurence Lins, Jan Van Den Abbeele, Annette Pays, Patricia Tebabi, R. David Britt, Alain Jacquet, Nicole Moguilevsky, Marc Dieu, John P. Kane, Patrick De Baetselier, Robert Brasseur, Étienne Pays	2003	383
13	Human cholesterol 7α-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype Journal of Clinical Investigation ·Clive R. Pullinger, Celeste Eng, Gerald Salen, Sarah Shefer, Ashok K. Batta, Sandra K. Erickson, Andrea Verhagen, Christopher R. Rivera, Sean J. Mulvihill, Mary J. Malloy, John P. Kane	2002	368
14	Influence of an asparagine to lysine mutation at amino acid 3516 of apolipoprotein B on low-density lipoprotein receptor binding Clinica Chimica Acta ·Dairena Gaffney, Clive R. Pullinger, D S O’Reilly, Pizzetto Rr, Isobel M. Cameron, J. Keith Vass, James Eiving, John P. Kane, Verne N. Schumaker, Gerald F. Watts, Chris J. Packard	2002	9
15	Lack of association of lipoprotein(a) levels with coronary calcium deposits in asymptomatic postmenopausal women Journal of the American College of Cardiology ·Masami Nishino, Mary J. Malloy, Josefina Naya-Vigne, Julie A. Russell, John P. Kane, Rita F. Redberg	2000	37
16	Analysis of hABC1 Gene 5′ End: Additional Peptide Sequence, Promoter Region, and Four Polymorphisms Biochemical and Biophysical Research Communications ·Clive R. Pullinger, Hideki Hakamata, Philippe Duchâteau, Celeste Eng, Bradley E. Aouizerat, Min Cho, Christopher J. Fielding, John P. Kane	2000	55
17	Rationale and Design of the Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering (MIRACL) Study11See Appendix Afor the list of participants in the MIRACL study. That Evaluates Atorvastatin in Unstable Angina Pectoris and in Non–Q-Wave Acute Myocardial Infarction The American Journal of Cardiology ·Gregory G. Schwartz, Michael F. Oliver, Michael Ezekowitz, Peter Ganz, David D. Waters, John P. Kane, Michele Texter, Milton L. Pressler, Donald M. Black, Bernard Chaitman, Anders Olsson	1998	67
18	Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death. Journal of Clinical Investigation ·Hobart W. Harris, Carl Grünfeld, Kenneth R. Feingold, Thomas E. Read, John P. Kane, Anna Jones, G�nther Busch, 加奈子横井, Joseph H. Rapp	1993	178
19	Familial chylomicronemia (type I hyperlipoproteinemia) due to a single missense mutation in the lipoprotein lipase gene. Journal of Clinical Investigation ·Detlev Ameis, Junji Kobayashi, R.C. Davis, Osnat Ben-Zeev, Mary J. Malloy, John P. Kane, Gabriel Brown, Hubert Wong, Afzaligrouh Zahra, Michael C. Schotz	1991	55
20	Ncol dimorphic site located 8kb 3′ to the human apolipoprotein AIV (APOA4) gene Nucleic Acids Research ·Roger Coleman, Mary J. Malloy, John P. Kane, Nachiappan Ramiah	1988	2

About John P. Kane

John P. Kane is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research, Cardiology and Cardiovascular Medicine, Surgery and Biochemistry, having authored 261 papers that have together received 16.8k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (78 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (77 papers), Cancer, Lipids, and Metabolism (59 papers), Lipid metabolism and disorders (53 papers), Cholesterol and Lipid Metabolism (36 papers), Peroxisome Proliferator-Activated Receptors (27 papers), Genetic Associations and Epidemiology (15 papers) and Antioxidant Activity and Oxidative Stress (12 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (6.2k citations), Cancer Research (3.2k citations), Surgery (7.2k citations), Cardiology and Cardiovascular Medicine (3.5k citations) and Biochemistry (928 citations). John P. Kane has collaborated with scholars based in United States, Japan and Canada. Frequent co-authors include Richard J. Havel, Mary J. Malloy, Clive R. Pullinger, S T Kunitake, D A Hardman, R J Havel, L Kotite, Harold E. Paulus, Robert L. Hamilton and Teizo Sata. Their work appears in journals such as Journal of Lipid Research, Journal of Clinical Investigation, Proceedings of the National Academy of Sciences, Biochemistry and Journal of clinical lipidology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact